Profiling flavonoid cytotoxicity in human breast cancer cell lines: Determination of structure-function relationships

Natural Product Communications

Volumn 9, Issue 5, 2014, Pages 597-606

  Yadegarynia, Sina ^a   Pham, Anh ^a   Ng, Alex ^a   Nguyen, Duong ^a   Lialiutska, Tetiana ^a   Bortolazzo, Anthony ^a   Sivryuk, Valentin ^a   Bremer, Martina ^a   White, J Brandon ^a  

^a SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle arrest; HER2; Mass spectrometry; Mitochondrial toxicity; p53

Indexed keywords

ADENOSINE TRIPHOSPHATE; APIGENIN; CATECHIN; FLAVONOID; GENISTEIN; KAEMPFEROL; MYRICETIN; NARINGENIN; QUERCETIN;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL CYCLE ARREST; CHEMICAL BINDING; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; EPITHELIUM CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; OUTER MEMBRANE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; FEMALE; FLAVONOIDS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901590706     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900501     Document Type: Article

References (48)

1. Williams RJ, Spencer JPE, Rice-Evans C. (2004) Flavonoids: Antioxidants or signalling molecules? Free Radical Biology & Medicine, 36, 838-849. (Pubitemid 38352901)
2. Surh YJ. (2003) Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 3, 768-780.
3. Ramos S. (2007) Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. Journal of Nutritional Biochemistry, 18, 427-442.
4. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell, 10, 515-527. (Pubitemid 44854747)
5. Rosenberg RS, Grass L, Jenkins DJ, Kendall CW, Diamandis EP. (1998) Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines. Biochemical & Biophyical Research Communications, 248, 935-939. (Pubitemid 28404525)
6. Long X, Fan M, Bigsby RM, Nephew KP. (2008) Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Molecular Cancer Therapeutics, 7, 2096-2108.
7. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E. (2000) Potent inhibitory action of red wine polyphenols on human breast cancer cells. Journal of Cellular Biochemistry, 78, 429-441. (Pubitemid 30491071)
8. Eto I. (2006) "Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells". Cancer Cell International, 6, 20.
9. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D, Ando S. (2001) Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Moecularl Pharmacology, 60, 595-602. (Pubitemid 32782656)
10. Rodgers EH, Grant MH. (1998) The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chemico-Biological Iinteractions, 116, 213-228. (Pubitemid 28543195)
11. Matsumura A, Ghosh A, Pope GS, Darbre PD. (2005) Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. The Journal of Steroid Biochemistry & Molecular Biology, 94, 431-443. (Pubitemid 40616404)
12. Wang TT, Sathyamoorthy N, Phang JM. (1996) Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-275. (Pubitemid 26091305)
13. Wang C, Kurzer MS. (1998) Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutrition & Cancer, 31, 90-100. (Pubitemid 28428068)
14. Castillo-Pichardo L, Martinez-Montemayor MM, Martinez JE, Wall KM, Cubano LA, Dharmawardhane S. (2009) Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clinical & Experimental Metastasis, 26, 505-516.
15. Chien SY, Wu YC, Chung JG, Yang JS, Lu HF, Tsou MF, Wood WG, Kuo SJ, Chen DR. (2009) Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Human & Experimental Toxicology, 28, 493-503.
16. Conklin CM, Bechberger JF, MacFabe D, Guthrie N, Kurowska EM, Naus CC. (2007) Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis, 28, 93-100. (Pubitemid 44942630)
17. Li L, Henry GE, Seeram NP. (2009) Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds. Journal of Agricultural And Food Chemistry, 57, 7282-7287.
18. Phromnoi K, Yodkeeree S, Anuchapreeda S, Limtrakul P. (2009) Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacologica Sinica, 30, 1169-1176.
19. Seo HS, Ju JH, Jang K, Shin I. (2011) Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phospho-p53 and p21 in normal and malignant estrogen receptor alpha-negative breast cells. Nutrition Research, 31, 139-146.
20. Chen D, Landis-Piwowar KR, Chen MS, Dou QP. (2007) Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Research, 9, R80.
21. Wang C, Kurzer MS. (1997) Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutrition & Cancer, 28, 236-247. (Pubitemid 27446650)
22. Mak P, Leung YK, Tang WY, Harwood C, Ho SM. (2006) Apigenin suppresses cancer cell growth through ERbeta. Neoplasia, 8, 896-904. (Pubitemid 44706239)
23. Kim BW, Lee ER, Min HM, Jeong HS, Ahn JY, Kim JH, Choi HY, Choi H, Kim EY, Park SP, Cho SG. (2008) Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biology & Therapy, 7, 1080-1089.
24. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH. (2008) Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta4 integrin function in MDA-MB-231 breast cancer cells. Toxicology & Applied Pharmacology, 226, 178-191.
25. Lin AS, Chang FR, Wu CC, Liaw CC, Wu YC. (2005) New cytotoxic flavonoids from Thelypteris torresiana. Planta Medica, 71, 867-870.
26. Li Y, Bhuiyan M, Sarkar FH. (1999) Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. International Journal of Oncology, 15, 525-533.
27. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. (1999) Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene, 18, 3166-3172. (Pubitemid 29261238)
28. Upadhyay S, Li G, Liu H, Chen YQ, Sarkar FH, Kim HR. (1995) bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. Cancer Research, 55, 4520-4524.
29. Choi EJ, Kim GH. (2009) Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. The Journal of Nutritional Biochemistry, 20, 285-290.
30. Hirano T, Oka K, Akiba M. (1989) Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Research Communications In Chemical Pathology And Pharmacology, 64, 69-78. (Pubitemid 19123229)
31. El-Zarruk AA, van den Berg HW. (1999) The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase. Cancer Letters, 142, 185-193. (Pubitemid 29304575)
32. Peterson TG, Ji GP, Kirk M, Coward L, Falany CN, Barnes S. (1998) Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. The American Journal of Clinical Nutrition, 68, 1505S-1511S. (Pubitemid 28550938)
33. Hakimuddin F, Paliyath G, Meckling K. (2004) Selective cytotoxicity of a red grape wine flavonoid fraction against MCF-7 cells. Breast Cancer Research And Treatment, 85, 65-79. (Pubitemid 38437983)
34. Upadhyay S, Neburi M, Chinni SR, Alhasan S, Miller F, Sarkar FH. (2001) Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clinical Cancer Research, 7, 1782-1789. (Pubitemid 32708649)
35. Sathyamoorthy N, Gilsdorf JS, Wang TT. (1998) Differential effect of genistein on transforming growth factor beta 1 expression in normal and malignant mammary epithelial cells. Anticancer Research, 18, 2449-2453. (Pubitemid 28386532)
36. Wang P, Henning SM, Heber D. (2010) Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS ONE, 5, e10202.
37. Peng L, Wang B, Ren P. (2005) Reduction of MTT by flavonoids in the absence of cells. Colloids and surfaces. B, Biointerfaces, 45, 108-111. (Pubitemid 41266927)
38. Walle T. (2007) Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Molecular Pharmaceutics, 4, 826-832.
39. Schutters K, Reutelingsperger C. (2010) Phosphatidylserine targeting for diagnosis and treatment of human diseases. Apoptosis : An International Journal on Programmed Cell Death, 15, 1072-1082.
40. Sakamoto T, Horiguchi H, Oguma E, Kayama F. (2010) Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. The Journal of Nutritional Biochemistry, 21, 856-864.
41. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Kubo T, Wakai K, Tamakoshi A. (2005) Association of serum phytoestrogen concentration and dietary habits in a sample set of the JACC Study. Journal of Epidemiology, 15 Suppl 2, S196-202. (Pubitemid 41410104)
42. White JB, Beckford J, Yadegarynia S, Ngo N, Lialiutska T, d'Alarcao M. (2012) Some natural flavonoids are competitive inhibitors of Caspase-1, - 3 and -7 despite their cellular toxicity. Food Chemistry, 131, 1453-1459.
43. Walle T, Ta N, Kawamori T, Wen X, Tsuji PA, Walle UK. (2007) Cancer chemopreventive properties of orally bioavailable flavonoids - methylated versus unmethylated flavones. Biochemical Pharmacology, 73, 1288-1296. (Pubitemid 46452585)
44. Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV. (2005) Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. The Journal of Biological Chemistry, 280, 5636-5645. (Pubitemid 40280043)
45. Hardie DG. (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes & Development, 25, 1895-1908.
46. Jung JH, Lee JO, Kim JH, Lee SK, You GY, Park SH, Park JM, Kim EK, Suh PG, An JK, Kim HS. (2010) Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation. Journal of Cellular Physiology, 223, 408-414.
47. Miller E. (2004) Apoptosis measurement by annexin v staining. Methods In Molecular Medicine, 88, 191-202.
48. Mullen P. (2004) Flow cytometric DNA analysis of human cancer cell lines. Methods In Molecular Medicine, 88, 247-255.